Storia in 6 fonti

Trump, accordo per farmaci antiobesità alla portata di tutti

Il presidente, Eli Lilly e Novo Nordisk hanno presentato un accordo per ridurre i prezzi dei popolari farmaci dimagranti Zepbound e Wegovy a base di GLP-1 per i programmi governativi Medicare e Medicaid

Raccontata da

giovedì 6 novembre 2025·forbes.com
Trump Says Obesity Drugmakers Will Cut GLP-1 Prices—Medicare Will Cover Some Costs
The deal also means Medicare will start covering obesity drugs for some patients for the first time beginning next year.
giovedì 6 novembre 2025·ilsole24ore.com
Trump, accordo per farmaci antiobesità alla portata di tutti
Il presidente, Eli Lilly e Novo Nordisk hanno presentato un accordo per ridurre i prezzi dei popolari farmaci dimagranti Zepbound e Wegovy a base di GLP-1 per i programmi…

giovedì 6 novembre 2025·

cnbc.com

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in high U.S. drug costs.

giovedì 6 novembre 2025·

bbc.com

Trump unveils deals to lower US weight-loss drug prices

US President Donald Trump announces agreements with drug makers Eli Lilly and Novo Nordisk.

giovedì 6 novembre 2025·

upi.com

Trump announces deal to lower prices for obesity drugs - UPI.com

Eli Lilly and Novo Nordisk officials have agreed to lower the cost of GLP-1 obesity drugs for Medicaid and Medicare recipients and those who pay directly.

giovedì 6 novembre 2025·

aljazeera.com

Weight-loss drug makers announce pricing agreement with Trump

The deal, which includes Eli Lilly and Novo Nordisk, will slash prices for Medicare and Medicaid programme recipients.

venerdì 7 novembre 2025·

cnbc.com

Millions more Americans could access obesity drugs after Trump's deals with Eli Lilly, Novo Nordisk

Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur more private insurers to follow suit.

Trump Says Obesity Drugmakers Will Cut GLP-1 Prices—Medicare Will Cover Some Costs